TrianglePUBLICATIONS · 35938863
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood Adv
- Publication date
- 2023 Feb 28
- First author
- Stefanski HE
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Stefanski HE
- type
- Author
- name
- Eaton A
- type
- Author
- name
- Baggott C
- type
- Author
- name
- Rossoff J
- type
- Author
- name
- Verneris MR
- type
- Author
- name
- Prabhu S
- type
- Author
- name
- Pacenta HL
- type
- Author
- name
- Phillips CL
- type
- Author
- name
- Talano JA
- type
- Author
- name
- Moskop A
- type
- Author
- name
- Margossian SP
- type
- Author
- name
- Myers GD
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Stefanski HE
- type
- Author
- name
- Eaton A
- type
- Author
- name
- Baggott C
- type
- Author
- name
- Rossoff J
- type
- Author
- name
- Verneris MR
- type
- Author
- name
- Prabhu S
- type
- Author
- name
- Pacenta HL
- type
- Author
- name
- Phillips CL
- type
- Author
- name
- Talano JA
- type
- Author
- name
- Moskop A
- type
- Author
- name
- Margossian SP
- type
- Author
- name
- Myers GD
- type
- Author
- bibliography ids
- nci-bib-4b625b816c5855cedb58b72a
- book metadata
- content sha256
- 4c7871f5f16e035d078a236430b09daa9d6f99ec7e4c88e03e94563c10c7d53a
- document type
- citation
- dois
- 10.1182/bloodadvances.2022007246
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35938863
- immutable id
- pubmed:35938863@4c7871f5f16e035d078a236430b09daa9d6f99ec7e4c88e03e94563c10c7d53a
- journal
- abbreviation
- Blood Adv
- issn electronic
- 2473-9537
- issn print
- 2473-9529
- issue
- 4
- name
- Blood advances
- nlm unique id
- 101698425
- pages
- 541-548
- volume
- 7
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35938863
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- 30b8c714a23aa8c2a4c13ae1603a14e5eda0b0685527d1571bfb657001f7d2d1
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2023 Feb 28
- precision
- day
- year
- 2023
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Preserved source evidence · Not medical advice